Back to School: How biopharma can reboot drug development. Access exclusive analysis here

RotaShield: Phase II data

Researchers at the not-for-profit International Medica Foundation reported data from a double-blind, African Phase II trial in 998 infants showing that oral RotaShield given once soon after birth and again 60 days

Read the full 321 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE